2021
DOI: 10.1038/s41588-020-00764-0
|View full text |Cite
|
Sign up to set email alerts
|

Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
239
0
6

Year Published

2021
2021
2022
2022

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 218 publications
(248 citation statements)
references
References 70 publications
3
239
0
6
Order By: Relevance
“…We have previously shown that the presence of the common variant HNF1A p.(I27L) reduces the age of diagnosis of HNF1A MODY 32 . Recent studies of monogenic cardiomyopathy, familial hypercholesterolemia and monogenic breast cancer also observed the impact of common variants on the phenotype [33][34][35] . Despite the relatively large size of our cohorts, we were limited by small numbers of carriers of individual pathogenic variants and were unable to evaluate modifiers.…”
Section: Discussionmentioning
confidence: 99%
“…We have previously shown that the presence of the common variant HNF1A p.(I27L) reduces the age of diagnosis of HNF1A MODY 32 . Recent studies of monogenic cardiomyopathy, familial hypercholesterolemia and monogenic breast cancer also observed the impact of common variants on the phenotype [33][34][35] . Despite the relatively large size of our cohorts, we were limited by small numbers of carriers of individual pathogenic variants and were unable to evaluate modifiers.…”
Section: Discussionmentioning
confidence: 99%
“…Tadros et al described left ventricular (LV) trait as one of such host factors with HCM-enforcing effects positively associated with LV wall thickness and LV ejection fraction while DCM-enforcing effects correlated with increased LV end systolic and end diastolic volumes. Furthermore, elevated diastolic pressure represents yet another substantial risk for developing HCM [20]. Collectively, these studies convincingly demonstrated the polygenic nature of HCM pathogenesis and revealed the complex interaction between common variants and modifiable host factors in modulating HCM disease progression.…”
Section: Genetic and Non-genetic Risk Modifiersmentioning
confidence: 68%
“…Notably, a polygenic risk score derived from such common variants after excluding sarcomere mutations stratifies disease-free survival in carriers of pathogenic or likely pathogenic sarcomere mutations. In support of this, another GWAS study by Harper et al identified similar common variants in sarcomere mutation negative HCM patients from which a risk score was derived and used to predict phenotypic severity in sarcomere variant carriers [20]. These two seminal studies thus provide the first evidence that a polygenic risk score based on HCM susceptibility variants may explain the interpersonal variability in disease severity among carriers of rare disease-causing variants.…”
Section: Genetic and Non-genetic Risk Modifiersmentioning
confidence: 87%
“…Detailed results are provided in Supplementary Table 7 and Supplementary Table 8 We identified common variants within genes implicated in cardiomyopathies (e.g. BAG3, FHOD3, PLN), suggesting sarcomere homeostasis during mechanical stress may affect diastolic function in both health and disease 37 . A further example is the identification of the gene of a key regulator of cardiac diastolic function, phospholamban (PLN), which modulates sarcoplasmic reticulum calcium-ATPase activity 38 .…”
Section: /23mentioning
confidence: 99%